Gilead appoints current Roche Pharmaceuticals CEO as new CEO and chairman
The board of directors at Gilead Sciences has announced it has chosen Daniel O’Day, the current CEO of Roche Pharmaceuticals...
Trending:
-
![Foreign pharma companies in China]()
Is China the next great hope for the pharma industry?
-
![Mallinckrodt spin off]()
Mallinckrodt to spin off its speciality generics business next year
-
![]()
Pat-INFORMED: the solution to drug patent procurement issues?
-
![Mylan valsartan-containing drugs recall]()
Mylan recalls all lots of blood pressure drugs containing valsartan
-
![UCB]()
UCB to invest £1bn in the UK Life Sciences Sector Deal
-
![]()
Will tech giants like Amazon and Google change the pharma sector forever?
Expert commentary & analysis from GlobalData
Allergan’s Phase III Botox trial for depression pushed to H2 2019
Foamix’s rosacea drug FMX103 splits views on sunburn risk
ASH 2018: Celgene’s Revlimid looks set for new approvals in NHL
November’s top stories
Most Read
Company releases
Sanitary Sieves for Medicinal Powders
Sri Krishna Pharmaceuticals is an established manufacturer of pharmaceutical products such as acetaminophen (paracetamol), folic acid, domperidone and furosemide, supplying...
OPT-DISS 410
MODEL 2500 SELECT
The Distek Model 2500 Select Bathless Dissolution System is the culmination of three generations of patented bathless technology with extremely...
EZFILL 4500
ECLIPSE 5300
The Distek Eclipse 5300 Automated Dissolution Sampler offers rapid, accurate sampling using precision syringe pumps.
Company whitepapers
End-to-End Process for Large-Scale Adenovirus Manufacturing
Pall CorporationDistek Model 2500 Dissolution System
Nymi™Qualification of Powdered Gelatin Agar by NIR Spectroscopy
ABB AnalyticalTMF Services
PhlexglobalDefining Ideal Modular Design for Effective Pharmaceutical Packaging
DividellaLiposome Technology
Polymun ScientificCognitive Load and Habit Formation in Pharmaceutical Plants
NSF International, Pharma BiotechCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Knight Cancer Institute Research Building, Oregon
Oregon Health & Science University’s (OHSU) Knight Cancer Institute built a new research building at South Waterfront district in south-west Portland, Oregon, US.
Seqirus Vaccine Manufacturing Facility Expansion, Holly Springs, US
Abzena’s Biotherapeutics Manufacturing Facility Relocation, San Diego
Astellas Institute for Regenerative Medicine Relocation
Medicago’s Vaccine Production Facility, Quebec, Canada
Clinical Trials
AbbVie halts phase III TAHOE trial of Rova-T for SCLC
Following advice from an independent data monitoring committee, biopharma company AbbVie has ceased enrolment in its TAHOE trial evaluating Rovalpituzumab Tesirine (Rova-T) as a second...
FDA grants ODD for AstraZeneca’s Fasenra to treat EGPA
Aimmune publishes phase III data for peanut allergy drug
Genomic profiling offers hope for rare cancer treatments
Foamix publishes top line phase III results for rosacea drug
Drug Development
CEPI and Imperial College London collaborate on Disease X vaccines project
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway and Imperial College London have formed an alliance to develop new vaccines against known as well...
Merck partners with Cyclica for AI-based screening of drug targets
SUDA and Zelda partner to develop medical grade cannabinoid spray
AbbVie halts phase III TAHOE trial of Rova-T for SCLC
Eisai and UCL deepen drug discovery alliance
Market Data
M&As this week: GlaxoSmithKline, Takeda, Procter & Gamble
GlaxoSmithKline (GSK) has agreed to acquire US-based cancer treatment developer Tesaro for $5.1bn.
Deals this week: Boehringer Ingelheim, UCB, Janssen Pharmaceutical
Mylan recalls all lots of blood pressure drugs containing valsartan
Takeda receives shareholders’ approval to acquire Shire
UCB to invest £1bn in the UK Life Sciences Sector Deal
Technology
Merck partners with Cyclica for AI-based screening of drug targets
Merck has signed an agreement to licence Canada-based Cyclica’s cloud-based in-silico proteome screening platform called Ligand Express to support its research efforts.
Fluidic Analytics gains funding for lab-tools products launch
Lupin launches chatbot ANYA for health-related queries
Elsevier introduces cloud-based platform for life sciences companies
Otsuka expands digital medicines alliance with Proteus Digital